SCHEMBL4601990

SCHEMBL4601990

CCCCOC(=O)NC(CC(C)N(C)C)C(=O)OCC(C)C

nearest known ligand 0.42

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
CHRNB2 P17787 4/20 0.42
CHRNA4 P43681 4/20 0.42
CHRNB4 P30926 3/20 0.42
CHRNA3 P32297 3/20 0.42
SMN1; SMN2 Q16637 4/20 0.36
NPC1 O15118 3/20 0.36
RAB9A P51151 3/20 0.36
HPGD P15428 2/20 0.36
KDM4E B2RXH2 1/20 0.36
ALDH1A1 P00352 1/20 0.36
MAPT P10636 1/20 0.36
MAPK1 P28482 1/20 0.36
MCL1 Q07820 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
EPHX1 P07099 1/20 0.36
TAS1R3 Q7RTX0 1/20 0.35
TAS1R1 Q7RTX1 1/20 0.35
ACHE P22303 6/20 0.35
BIRC2 Q13490 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4632006 0.88 CHRNB2 (0.44) CHRNB2CHRNA4CHRNB4CHRNA3SMN1; SMN2
SCHEMBL4603597 0.82 CTSL (0.38) CHRNB2CHRNA4CHRNB4CHRNA3SMN1; SMN2
SCHEMBL4632097 0.78 CTSK (0.45) SMN1; SMN2L3MBTL1
SCHEMBL4632101 0.78 CTSK (0.45) SMN1; SMN2L3MBTL1
SCHEMBL10703068 0.77 TAS1R3 (0.44) SMN1; SMN2NPC1RAB9AHPGDALDH1A1
SCHEMBL4632761 0.76 CHRNB2 (0.50) CHRNB2CHRNA4CHRNB4CHRNA3SMN1; SMN2
SCHEMBL2455888 0.74 PLA2G2A (0.55) ALDH1A1MAPT
SCHEMBL1068731 0.74 PLA2G2A (0.55) ALDH1A1MAPT
SCHEMBL6824840 0.74 PLA2G2A (0.55) ALDH1A1MAPT
SCHEMBL6828291 0.73 CTSL (0.40) SMN1; SMN2NPC1RAB9AHPGDKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1915351-A1 QUINAZOLINE DERIVATIVES USEFUL IN CANCER TREATMENT SCHERING CORPORATION (US) 2008-04-30 EP disclosed
WO-2007011618-A1 QUINAZOLINE DERIVATIVES USEFUL IN CANCER TREATMENT SCHERING CORPORATION (US) 2007-01-25 WO disclosed